The Patent Finder

Shire Canada Inc.

Also on record
Records under this name other than patents Shire Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Shire Canada Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,955,835Stereoselective Process for the Production of Dioxolane Nucleoside Analogues
Formerly held
Term ended
Term ended Jun 13, 2025 · High confidence
Term endedTerm ended Jun 13, 2025High confidence
US 7,465,465Pharmaceutical Formulation Comprising Lanthanum Compounds
Formerly held
Term ended
Term ended Oct 9, 2024 · High confidence
Term endedTerm ended Oct 9, 2024High confidence
US 6,645,972Methods of Treating Leukemia
Formerly held
Term ended
Term ended Nov 4, 2022 · High confidence
Term endedTerm ended Nov 4, 2022High confidence
US 6,800,639Pharmaceutical Combination for the Treatment of Cancer
Formerly held
Term ended
Term ended Mar 25, 2022 · High confidence
Term endedTerm ended Mar 25, 2022High confidence
US 8,399,655Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Lapsed on the fee record
Ended Mar 19, 2021 · USPTO record
Lapsed on the fee recordEnded Mar 19, 2021USPTO record
US 6,630,480Methods of treating leukemia
Formerly held
Term ended
Term ended Mar 28, 2020 · USPTO record
Term endedTerm ended Mar 28, 2020USPTO record
US 6,747,036Methods of Treating Leukemia
Formerly held
Term ended
Term ended Mar 28, 2020 · Medium confidence
Term endedTerm ended Mar 28, 2020Medium confidence
US 7,968,703Process and Methods for the Preparation of Optically Active CIS-2-Hydroxymethyl-4- (CYTOSIN-1'-YL) -1,3-Oxathiolane or Pharmaceutically Acceptable Salts Thereof
Lapsed on the fee record
Ended Jun 28, 2019 · High confidence
Lapsed on the fee recordEnded Jun 28, 2019High confidence
US 6,180,6391,3-oxathiolane nucleoside analogues
Term ended
Term ended Jan 30, 2018 · USPTO record
Term endedTerm ended Jan 30, 2018USPTO record
US 5,348,946Heteroanthracycline antitumor analogs
Term ended
Term ended no later than Sep 20, 2014 · Low confidence
Term endedTerm ended no later than Sep 20, 2014Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited